Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: the MALACHITE-I/II trials
dc.contributor.author | Dore, Gregory J. | |
dc.contributor.author | Conway, Brian | |
dc.contributor.author | Luo, Yan | |
dc.contributor.author | Janczewska, Ewa | |
dc.contributor.author | Knysz, Brygida | |
dc.contributor.author | Liu, Yan | |
dc.contributor.author | Streinu-Cercel, Adrian | |
dc.contributor.author | Caruntu, Florin Alexandru | |
dc.contributor.author | Curescu, Manuela | |
dc.contributor.author | Skoien, Richard | |
dc.contributor.author | Ghesquiere, Wayne | |
dc.contributor.author | Mazur, Włodzimierz | |
dc.contributor.author | Soza, Alejandro | |
dc.contributor.author | Fuster, Francisco | |
dc.contributor.author | Greenbloom, Susan | |
dc.contributor.author | Motoc, Adriana | |
dc.contributor.author | Arama, Victoria | |
dc.contributor.author | Shaw, David | |
dc.contributor.author | Tornai, István | |
dc.contributor.author | Sasadeusz, Joseph | |
dc.contributor.author | Dalgard, Olav | |
dc.contributor.author | Sullivan, Danielle | |
dc.contributor.author | Liu, Xuan | |
dc.contributor.author | Kapoor, Mudra | |
dc.contributor.author | Campbell, Andrew | |
dc.contributor.author | Podsadecki, Thomas | |
dc.date.accessioned | 2019-01-11T11:44:40Z | |
dc.date.available | 2019-01-11T11:44:40Z | |
dc.date.issued | 2016 | |
dc.date.oa | 2019-03-05 | |
dc.date.pasync | 2023-03-22T00:07:30Z | |
dc.date.updated | 2019-05-24T00:30:18Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Journal Of Hepatology. -64 : 1 (2016), p. 19-28. -J. Hepatol. - 0168-8278 | |
dc.identifier.doi | http://dx.doi.org/10.1016/j.jhep.2015.08.015 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM076632 | |
dc.identifier.scopus | 84961817155 | |
dc.identifier.uri | http://hdl.handle.net/2437/262947 | |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S0168827815005577 | |
dc.identifier.wos | 000366665700007 | |
dc.language | eng | |
dc.rights.access | open access article | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: the MALACHITE-I/II trials | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nem elérhető
- Név:
- FILE_UP_2_2016 J Hepatol Malachite I_II.pdf
- Méret:
- 870.76 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat